Bill Nihill

Bill Nihill is a seasoned professional with 28 years in the pharmaceutical industry, focusing on sales and marketing across various disease states such as Alzheimer's and cardiovascular conditions. They have held pivotal roles at prominent companies including Lilly and AbbVie, where they currently serve as Director II of the U.S. Market Access Pipeline, leading a team to develop early market access strategies. Throughout their career, Nihill specialized in building and implementing reimbursement strategies for significant product launches, including FORTEO and Cymbalta. They earned a B.S. in Marketing from Indiana University Bloomington.